Table 1.
Comparing the baseline characteristics of mucormycosis between COVID-19 and non-COVID-19 patients
| Variables | Total (n=64) | COVID-19 | p-value | |
|---|---|---|---|---|
| Yes (n=43) | No (n=21) | |||
| Gender | ||||
| Female | 30 (100) | 20 (66.7) | 10 (33.3) | 0.934 |
| Male | 34 (100) | 23 (37.6) | 11 (23.4) | |
| Age (years) | 53.40±10.32 | 52.16±10.63 | 55.95 ±9.38 | 0.170 |
| Body mass index (kg/m 2 ) | 25.47±3.66 | 26.16 ±3.32 | 23.96 ±4.04 | 0.062 |
| Length of stay Median (IQR) | 16 (23.5) | 20 (24) | 15 (18) | 0.710 |
| Symptoms | ||||
| Sore eyes | 41 (100) | 27 (65.9) | 14 (34.1) | 0.760 |
| Swelling of eyes and face | 38 (100) | 25 (65.8) | 13 (34.2) | 0.773 |
| Blurred vision | 23 (100) | 16 (69.6) | 7 (30.4) | 0.762 |
| Cough | 19 (100) | 19 (100) | 0 (0) | <0.001 |
| Weakness | 15 (100) | 11 (73.3) | 4 (26.7) | 0.403 |
| Headache | 13 (100) | 9 (69.2) | 4 (30.8) | 0.507 |
| Fever | 12 (100) | 7 (56.3) | 5 (41.7) | 0.570 |
| Shortness of breath | 12 (100) | 12 (100) | 0 (0) | 0.006 |
| Symptoms to diagnosis | ||||
| Median (IQR) | 5 (4) | 6 (6) | 5 (3) | 0.824 |
| Presentation | ||||
| Acute | 59 (100) | 40 (67.8) | 19 (32.2) | 0.027 |
| Subacute | 5 (100) | 3 (60) | 2 (40) | 0.534 |
| Risk factors/ Underlying | ||||
| Smoking | 31 (100) | 23 (74.2) | 8 (25.8) | 0.247 |
| Opium | 4 (100) | 1 (25) | 3 (75) | 0.099 |
| Alcohol | 2 (100) | 1 (50) | 1 (50) | 1.000 |
| Coronary artery disease | 11 (100) | 10 (90.9) | 1 (9.1) | 0.085 |
| Diabetes mellitus | 45 (100) | 32 (71.1) | 13 (28.9) | 0.304 |
| Dyslipidemia | 18 (100) | 14 (77.8) | 4 (22.2) | 0.259 |
| Hypertension | 26 (100) | 17 (65.4) | 9 (34.6) | 0.799 |
| Drug History | ||||
| Immunosuppressive | 10 (100) | 4 (40) | 6 (60) | 0.068 |
| Anticoagulant | 4 (100) | 3 (75) | 1 (25) | 1.000 |
| Antiplatelet aggregation | 22 (100) | 16 (72.7) | 6 (27.3) | 0.495 |
| Antidiabetic | 43 (100) | 30 (69.8) | 13 (30.2) | 0.529 |
| Antihypertensive | 28 (100) | 19 (67.9) | 9 (32.1) | 0.920 |
| Laboratory tests | ||||
| ESR (sec) | 56.34±33.50 | 60.32±31.74 | 47.94 ±36.38 | 0.187 |
| Albumin (g/dL) | 3.19±0.58 | 3.18±0.64 | 3.22 ±0.44 | 0.822 |
| HbA1C (g/dL) | 9.54 ±2.99 | 9.90±2.91 | 8.63 ±3.07 | 0.166 |
| Blood urea nitrogen (mg/dL) | 38.2 (31.8) | 39 (36.7) | 34.6 (27.45) | 0.139 |
| Blood sugar (mg/dL) | 189 (211) | 180 (210.75) | 192 (310) | 0.974 |
Data are presented as mean ± standard deviation (SD), frequency (%), and median (IQR). ESR: erythrocyte sedimentation rate; HbA1C: hemoglobin A1c.